David Dingli, MD, PhD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
David Dingli, MD, PhD

David Dingli, MD, PhD

Healthcare Professional
Consultant
Department of Hematology
Mayo Clinic
200 First St. SW
Rochester, Minnesota, United States

Dr. David Dingli is a hematology and internal medicine specialist at Mayo Clinic, Rochester, Minnesota and his clinical practice is devoted to patients with plasma cell disorders and chronic myeloid leukemia. He completed his Residency and Fellowship from Mayo Clinic College of Medicine. Dr. David Dingli pursued his PhD in molecular biology from Mayo Clinic College of Medicine and Science.

Dr. Dingli has experience in treating conditions like amyloidosis, monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma, paroxysmal nocturnal hemoglobinuria, plasma cell disorders, POEMS syndrome, Schnitzler syndrome, and Waldenstrom macroglobulinemia.

 

Representative Publications:

Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis

Primary systemic amyloidosis in patients with Waldenström macroglobulinemia

Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method 

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma 

Natural history of multiple myeloma with de novo del(17p) 

In Vivo Imaging of Oncolytic Measles Virus Propagation with Single-Cell Resolution 

view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close